Home
Conditions
Neuroectodermal Tumors

Clinical trial condition

Neuroectodermal Tumors

Explore clinical trials studying Neuroectodermal Tumors. Study availability and eligibility vary by location and protocol.

6,002 public trials 1,214 recruiting studies

Refine in advanced search Browse all conditions

Neuroectodermal Tumors trial results

Completed

Interferon Alfa or No Further Therapy Following Surgery in Treating Patients With Stage II, Stage III, or Recurrent Melanoma

NCT00002892

Conditions: Melanoma, Melanoma (Skin), Neoplasms, +10 more
Locations: Royal Free Hospital Hampstead, London, England, United Kingdom

St. James's Hospital Leeds, England, United Kingdom

University Hospitals of Leicester Leicester, England, United Kingdom

Guy's, King's and St. Thomas' Hospitals Trust London, England, United Kingdom

View all 14 locations

View Trial Details

Completed

ABI-007 in Treating Patients With Inoperable Locally Recurrent or Metastatic Melanoma

NCT00081042

Conditions: Melanoma, Melanoma (Skin), Neoplasms, +10 more
Locations: Jonsson Comprehensive Cancer Center at UCLA Los Angeles, California, United States

View Trial Details

Completed

Calcitriol Plus Carboplatin in Treating Patients With Advanced Solid Tumors

NCT00008086

Conditions: Astrocytoma, Brain Diseases, Brain Neoplasms, +29 more
Locations: University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States

View Trial Details

Completed

Therapy Based on Stage of Disease and Risk Assessment in Treating Children With Neuroblastoma

NCT00002802

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +7 more
Locations: University of Cologne Frechen, Germany

View Trial Details

Completed

Combination Chemotherapy or Observation Following Surgery in Treating Infants With Neuroblastoma

NCT00002803

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +7 more
Locations: University of Cologne Frechen, Germany

View Trial Details

Completed

Temozolomide Compared to Procarbazine, Lomustine, and Vincristine in Treating Patients With Recurrent Malignant Glioma

NCT00052455

Conditions: Astrocytoma, Brain Diseases, Brain Neoplasms, +16 more
Locations: Medical Research Council Clinical Trials Unit London, England, United Kingdom

View Trial Details

Completed

A Phase I/II Study of Dasatinib and Dacarbazine

NCT00597038

Conditions: Melanoma, Metastatic Melanoma, Neoplasms, +10 more
Locations: Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco San Francisco, California, United States

H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States

View Trial Details

Completed

R(+)XK469 in Treating Patients With Advanced Neuroblastoma

NCT00028522

Conditions: Disseminated Neuroblastoma, Localized Unresectable Neuroblastoma, Neoplasms, +11 more
Locations: University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States

View Trial Details

Completed

Imaging Malignant Glioma With 68Ga-DOTATOC PET/CT

NCT01460706

Conditions: Glioma, Neoplasms, Neoplasms by Histologic Type, +5 more
Locations: Turku PET Centre, Turku University Hospital Turku, Finland

View Trial Details

Completed

Phase II Trial Of ZK-EPO (ZK 219477) (Sagopilone) In Metastatic Melanoma

NCT00598507

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States

View Trial Details

Neuroectodermal Tumors

Neuroectodermal Tumors trial results

Related conditions